Artiva Biotherapeutics, Inc. (ARTV), a biopharmaceutical company specializing in cellular immunotherapies with a current market capitalization of $135 million, has announced the appointment of Daniel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback